FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386162548> ?p ?o ?g. }

• W4386162548 abstract "Abstract Background Gaucher’s disease (GD), a rare condition, represents the most common lysosomal storage disorder. The cardinal manifestations of GD are fatigue, hepatosplenomegaly, anemia, thrombocytopenia, bone pain, and bone infarction, thereby culminating in a marked deterioration of patients’ quality of life (QoL). Patient-reported outcomes (PROs) offer valuable insights into the impact of GD on patients’ QoL and symptoms. This systematic review aimed to identify and analyze PROs and outcome measures in GD patients. Methods We systematically searched PubMed, Web of Science Core Collections, EMBASE, SCOPUS, Cochrane Library, PsycINFO, Wan Fang Data, China National Knowledge Infrastructure (CNKI), and the Chinese Biomedical Literature Database (CBM). The methodological quality of the included studies was assessed using a mixed methods assessment tool. Results A total of 33 studies were identified, encompassing 24 distinct patient-reported outcome instruments, with the most frequently employed instrument being the SF-36. The study designs included eighteen cross-sectional studies, seven pre- and post-intervention investigations, three randomized controlled trials, two cohort studies, two qualitative inquiries, and one validation study. These studies explored diverse domains such as the QoL and cardinal symptoms (e.g., fatigue, pain, bleeding, cognition, social relationships, and psychological functioning) in patients with GD. Furthermore, significant attention was directed towards the appraisal of the therapeutic benefits of various interventions in patients with GD. A novel GD-specific instrument has also been developed, which has two applied versions: a 24-item variant for routine clinical monitoring and a 17-item form for use in clinical trials. Conclusion PROs have garnered increased attention and concern in the realm of GD. Despite this progress, it is noteworthy that the instruments used to measure PROs in GD are still predominantly generic instruments. While researchers have endeavored to develop and validate a disease-specific instrument, currently the use of this instrument is limited. Owing to several challenges, including the small number of patients, heterogeneity of the disease, and cross-regional discrepancies in study findings, GD poses substantial difficulties in the measurement of QoL and development of instruments. Consequently, patients with GD require more dependable measurement instruments that accurately reflect their QoL, efficacy of treatment, and facilitate healthcare decision-making." @default.
• W4386162548 created "2023-08-26" @default.
• W4386162548 creator A5034444185 @default.
• W4386162548 creator A5040291465 @default.
• W4386162548 creator A5043629216 @default.
• W4386162548 creator A5073109278 @default.
• W4386162548 creator A5086688640 @default.
• W4386162548 date "2023-08-25" @default.
• W4386162548 modified "2023-10-17" @default.
• W4386162548 title "Patient-reported outcomes in Gaucher’s disease: a systematic review" @default.
• W4386162548 cites W1560800726 @default.
• W4386162548 cites W1911783858 @default.
• W4386162548 cites W1974747412 @default.
• W4386162548 cites W1987253435 @default.
• W4386162548 cites W1989812344 @default.
• W4386162548 cites W2000125278 @default.
• W4386162548 cites W2012506180 @default.
• W4386162548 cites W2033280100 @default.
• W4386162548 cites W2038999915 @default.
• W4386162548 cites W2047164992 @default.
• W4386162548 cites W2069539724 @default.
• W4386162548 cites W2070309415 @default.
• W4386162548 cites W2088555058 @default.
• W4386162548 cites W2091356228 @default.
• W4386162548 cites W2094750660 @default.
• W4386162548 cites W2094914698 @default.
• W4386162548 cites W2099537015 @default.
• W4386162548 cites W2111640917 @default.
• W4386162548 cites W2145695460 @default.
• W4386162548 cites W2145814377 @default.
• W4386162548 cites W2153890841 @default.
• W4386162548 cites W2292332419 @default.
• W4386162548 cites W2322286659 @default.
• W4386162548 cites W2588291989 @default.
• W4386162548 cites W2735351778 @default.
• W4386162548 cites W2736261406 @default.
• W4386162548 cites W2750879832 @default.
• W4386162548 cites W2766189537 @default.
• W4386162548 cites W2782908833 @default.
• W4386162548 cites W2789909047 @default.
• W4386162548 cites W2794014169 @default.
• W4386162548 cites W2796621825 @default.
• W4386162548 cites W2893139922 @default.
• W4386162548 cites W2900190335 @default.
• W4386162548 cites W2921138927 @default.
• W4386162548 cites W2929961692 @default.
• W4386162548 cites W2946990928 @default.
• W4386162548 cites W2972357383 @default.
• W4386162548 cites W2990516842 @default.
• W4386162548 cites W2991530027 @default.
• W4386162548 cites W3000192889 @default.
• W4386162548 cites W3010135593 @default.
• W4386162548 cites W3013715031 @default.
• W4386162548 cites W3028567993 @default.
• W4386162548 cites W3092157717 @default.
• W4386162548 cites W3107783777 @default.
• W4386162548 cites W3118615836 @default.
• W4386162548 cites W3119522792 @default.
• W4386162548 cites W3131624522 @default.
• W4386162548 cites W3137627835 @default.
• W4386162548 cites W3187390192 @default.
• W4386162548 cites W4200474846 @default.
• W4386162548 cites W4205236753 @default.
• W4386162548 cites W4234505218 @default.
• W4386162548 cites W4238460276 @default.
• W4386162548 cites W4247729478 @default.
• W4386162548 cites W82926723 @default.
• W4386162548 doi "https://doi.org/10.1186/s13023-023-02844-w" @default.
• W4386162548 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37626429" @default.
• W4386162548 hasPublicationYear "2023" @default.
• W4386162548 type Work @default.
• W4386162548 citedByCount "0" @default.
• W4386162548 crossrefType "journal-article" @default.
• W4386162548 hasAuthorship W4386162548A5034444185 @default.
• W4386162548 hasAuthorship W4386162548A5040291465 @default.
• W4386162548 hasAuthorship W4386162548A5043629216 @default.
• W4386162548 hasAuthorship W4386162548A5073109278 @default.
• W4386162548 hasAuthorship W4386162548A5086688640 @default.
• W4386162548 hasBestOaLocation W43861625481 @default.
• W4386162548 hasConcept C118552586 @default.
• W4386162548 hasConcept C126322002 @default.
• W4386162548 hasConcept C159110408 @default.
• W4386162548 hasConcept C168563851 @default.
• W4386162548 hasConcept C17744445 @default.
• W4386162548 hasConcept C1862650 @default.
• W4386162548 hasConcept C189708586 @default.
• W4386162548 hasConcept C199539241 @default.
• W4386162548 hasConcept C27415008 @default.
• W4386162548 hasConcept C2776478404 @default.
• W4386162548 hasConcept C2779134260 @default.
• W4386162548 hasConcept C2779473830 @default.
• W4386162548 hasConcept C2779549880 @default.
• W4386162548 hasConcept C2779951463 @default.
• W4386162548 hasConcept C71924100 @default.
• W4386162548 hasConceptScore W4386162548C118552586 @default.
• W4386162548 hasConceptScore W4386162548C126322002 @default.
• W4386162548 hasConceptScore W4386162548C159110408 @default.
• W4386162548 hasConceptScore W4386162548C168563851 @default.
• W4386162548 hasConceptScore W4386162548C17744445 @default.
• W4386162548 hasConceptScore W4386162548C1862650 @default.

• next